These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 28025657)

  • 1. miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway.
    Yang JJ; Tao H; Liu LP; Hu W; Deng ZY; Li J
    Inflamm Res; 2017 Apr; 66(4):341-352. PubMed ID: 28025657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.
    Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM
    Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis.
    Yang JJ; Tao H; Hu W; Liu LP; Shi KH; Deng ZY; Li J
    Cell Signal; 2014 Nov; 26(11):2381-9. PubMed ID: 25049078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation.
    Sun X; He Y; Ma TT; Huang C; Zhang L; Li J
    Mol Cell Biochem; 2014 Mar; 388(1-2):11-23. PubMed ID: 24242045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway.
    Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y
    DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
    Wu SM; Li TH; Yun H; Ai HW; Zhang KH
    Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
    Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
    Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of liver cirrhosis achieved by inhibitory effect of miR-454 on hepatic stellate cells activation and proliferation via Wnt10a.
    Wang YZ; Zhang W; Wang YH; Fu XL; Xue CQ
    J Biochem; 2019 Apr; 165(4):361-367. PubMed ID: 30535384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-22 ameliorates liver fibrosis through miR-200a/beta-catenin.
    Hu BL; Shi C; Lei RE; Lu DH; Luo W; Qin SY; Zhou Y; Jiang HX
    Sci Rep; 2016 Nov; 6():36436. PubMed ID: 27819314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
    Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
    Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
    Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSC-derived exosomal miR-199a-5p promotes HSC activation and hepatocyte EMT via targeting SIRT1 in hepatic fibrosis.
    Lu H; Zhang R; Zhang S; Li Y; Liu Y; Xiong Y; Yu X; Lan T; Li X; Wang M; Liu Z; Zhang G; Li J; Chen S
    Int Immunopharmacol; 2023 Nov; 124(Pt B):111002. PubMed ID: 37804655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MeCP2 silencing of LncRNA H19 controls hepatic stellate cell proliferation by targeting IGF1R.
    Yang JJ; Liu LP; Tao H; Hu W; Shi P; Deng ZY; Li J
    Toxicology; 2016 Jun; 359-360():39-46. PubMed ID: 27350269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4.
    He Y; Huang C; Sun X; Long XR; Lv XW; Li J
    Cell Signal; 2012 Oct; 24(10):1923-30. PubMed ID: 22735812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
    Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
    Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling.
    Zhang K; Zhang YQ; Ai WB; Hu QT; Zhang QJ; Wan LY; Wang XL; Liu CB; Wu JF
    World J Gastroenterol; 2015 Jan; 21(3):878-87. PubMed ID: 25624721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways.
    Fang B; Wen S; Li Y; Bai F; Wei Y; Xiong Y; Huang Q; Lin X
    Int Immunopharmacol; 2021 Mar; 92():107208. PubMed ID: 33444919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1.
    Qi F; Hu JF; Liu BH; Wu CQ; Yu HY; Yao DK; Zhu L
    World J Gastroenterol; 2015 Sep; 21(34):9900-15. PubMed ID: 26379395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.
    Tian XF; Ji FJ; Zang HL; Cao H
    PLoS One; 2016; 11(7):e0158657. PubMed ID: 27387128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation.
    Liao J; Zhang Z; Yuan Q; Liu Q; Kuang J; Fang Y; Hu X
    Toxicol Lett; 2021 Jan; 336():21-31. PubMed ID: 33069761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.